D007110PhysiologyG12.450.050.370890.996694Immunity, Activeprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.3735780.004714998research area of0.3748170.004730638subject area forMicrobiology8609411Gajewski TF, Fallarino F, Uyttenhove C, Boon TJournal of immunology (Baltimore, Md. : 1950)Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J Immunol. 1996 Apr 15; 156(8):2909-17.J Immunol1996-04-15T00:00:001996Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.Comm: Developmental BiologyHarinderSinghHarinder Singh0.000000000000000.000000000000003073Singh, HarinderPROFESSOR 16459066Yu P, Rowley DA, Fu YX, Schreiber HCurrent opinion in immunologyThe role of stroma in immune recognition and destruction of well-established solid tumors. Curr Opin Immunol. 2006 Apr; 18(2):226-31.Curr Opin Immunol2006-02-03T00:00:002006The role of stroma in immune recognition and destruction of well-established solid tumors.17900357Folcik VA, An GC, Orosz CGTheoretical biology & medical modellingThe Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunity. Theor Biol Med Model. 2007 Sep 27; 4:39.Theor Biol Med Model2007-09-27T00:00:002007The Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunity.ShabaanaKhaderShabaana Khader41.7886000000000087.598699999999994229Khader, ShabaanaProfessor20112107Lin Y, Slight SR, Khader SASeminars in immunopathologyTh17 cytokines and vaccine-induced immunity. Semin Immunopathol. 2010 Mar; 32(1):79-90.Semin Immunopathol2010-01-30T00:00:002010Th17 cytokines and vaccine-induced immunity.MedicinePathologyUniversity of ChicagoHansSchreiberHans Schreiber41.78927490000000-87.601250000000001921Schreiber, HansProfessorAlanLeffAlan Leff41.78927490000000-87.601250000000002537Leff, AlanEmeritus/EmeritaThomas F.GajewskiThomas F. Gajewski41.78927490000000-87.60125000000000355Gajewski, Thomas F.Professortrue1PROFESSOR PROFESSOR true1Emeritus/EmeritaEmeritus/Emeritatrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor19818654Spooner CJ, Cheng JX, Pujadas E, Laslo P, Singh HImmunityA recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity. 2009 Oct 16; 31(4):576-86.Immunity2009-10-08T00:00:002009A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates.